Extracorporeal Shock Wave Therapy (ESWT)
This policy governs use and coverage of extracorporeal shock wave therapies (including ESWL and low-intensity ESWT) for Priority Health members, specifying medically necessary indications and treatments considered not medically necessary or experimental.
Added Extracorporeal Shock Wave Lithotripsy as medically necessary for treatment of urolithiasis.
Added additional non-covered services for extracorporeal shock wave therapy (ESWT).
New Medical/Professional Society Guidelines, Government Regulations, FDA/Regulatory, and Policy Scope sections were added.
Policy was restructured to first specify inclusion (lithotripsy) and second specify ESWT conditions that are not medically necessary.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.